The drug activity of rifampicin (RFP) and capreomycin (CPM), viomycin (VM) or kanamycin (KM) against
Mycobacterium tuberculosis was examined
in vitro. Thirty strains tested were isolated from the in-patients with pulmonary tuberculosis. KIRCHNER agar containing 10% albumin was used for the examination.
(1) The strains resistant to 100 mcg/ml of CPM, VM or KM were susceptible to RFP, and the strains resistant to 100 mcg/ml of RFP were also susceptible to CPM, VM or KM.
(2) Therefore, in the strains isolated from the patients, no cross resistance between RFP and CPM, VM or KM was observed.
View full abstract